Daniel R. Budman

Ig V Gene Mutation Status and CD38 Expression As Novel Prognostic Indicators in Chronic Lymphocytic Leukemia

Rajendra N. Damle, Tarun Wasil, Franco Fais et al. · Blood · 1999 · 2.6K citations

Medicine, Hematology, Oncology +12

c-erbB-2 Expression and Response to Adjuvant Therapy in Women with Node-Positive Early Breast Cancer

Hyman B. Muss, Ann D. Thor, Donald A. Berry et al. · New England Journal of Medicine · 1994 · 968 citations · Full text

Medicine, Oncology, Breast Oncology +15

Estrogen-Receptor Status and Outcomes of Modern Chemotherapy for Patients With Node-Positive Breast Cancer

Donald A. Berry, Constance Cirrincione, I. Craig Henderson et al. · JAMA · 2006 · 731 citations · Full text

Medicine, Endocrinology, Oncology +17

erbB-2, p53, and Efficacy of Adjuvant Therapy in Lymph Node-Positive Breast Cancer

Ann D. Thor, Donald A. Berry, Daniel R. Budman et al. · JNCI Journal of the National Cancer Institute · 1998 · 618 citations · Full text

Medicine, Oncology, Pharmacology +16

Dose and Dose Intensity as Determinants of Outcome in the Adjuvant Treatment of Breast Cancer

Daniel R. Budman, Donald A. Berry, Constance Cirrincione et al. · JNCI Journal of the National Cancer Institute · 1998 · 582 citations

Medicine, Oncology, Pharmacology +17